- Home
- Industry Reports
- Biotechnology
- Healthcare
- Global Organs on Chips Market – Size, Outlook, Trends and Forecast (2023 – 2030)
An organ-on-a-chip is a microfluidic cell culture device, which is developed by microchip manufacturing methods which contain continuously perfused chambers inhabited by living cells arranged to simulate tissue and organ-level physiology. The organs-on-chips market is expected to reach $85.19 Million by 2024 from $9.6 Million in 2017, at a CAGR of 36.6%. Rising number of partnerships and collaborations between companies and Increasing focus on developing alternatives for animal testing models are the drivers that boost the market growth. Growing focus on drug discovery activities and the development of multiple organs on a chip model are the major opportunities for the market. On the flip side, the complexity of organs on chips models and issues related to the incorporation of organs on chips technologies are the restraints that hamper the market growth.
Research Study Objectives:
- Define, estimate, and forecast the Organs on Chips market statistics by offering, type, application, end user and regions concerning the individual growth drivers, market trends and their contribution toward the Organs on Chips market growth
- Provides comprehensive information regarding the key factors influencing the market growth (Drivers, Restraints &Challenges, and Opportunities)
- Estimate & forecast the market size of all the segments concerning geographies including North America, Europe, Asia Pacific (APAC), South America and the Middle East and Africa (MEA).
- Recent competitive developments including M&A (Mergers and Acquisitions), Partnerships, and Product Innovations are provided in the Organs on Chips Market Analysis report.
- Analysis and conclusions on the future Organs on Chips market outlook.
Top-down and bottom-up approaches are used to validate the Organs on Chips Market Size and are used to estimate the size of other dependent submarkets. Key players in the market are identified through various secondary sources; databases including Bloomberg Businessweek, Hoovers, Factiva, journals and associations and the market revenues are estimated and are thoroughly validated through primary and secondary research. Secondary research involves the study of annual and financial reports of top players in the market, whereas primary research includes extensive interviews with the KoL’s such as CEOs, directors, board members, VP’s, sales managers, engineers, marketing executives, technicians, account managers, investors, strategic decision makers and others. The Organs on Chips Market shares and breakdowns are determined using secondary sources and are verified by the primary sources. All possible parameters/factors that are affecting the Organs on Chips market demand are covered in the research study are verified through primary research, analysed and interpreted to get the final qualitative and quantitative data. This data is collected and added with detailed analysis from Envision Inteligence and presented in this report.
The scope of the Report
The Organs on Chips market segmentation is as follows:
By Offering
- Products
- Services
By Type
- Kidney
- Lung
- Heart
- Other Organs
By Application
- Drug Discovery
- Physiological Model Development
- Toxicology Research
By End User
- Cosmetics Industry
- Pharmaceutical & Biotechnology Companies
- Academic & Research Institutes
- Other End Users
Geographical Analysis:
Organs on Chips Market is segmented by geography into North America, South America, Europe, APAC and Middle East & Africa. U.S., Canada, Mexico and Costa Rica are analysed under North American region which is usually turning as the hotspot in the market. The South American region is further segregated into Brazil, Argentina, Chile, Columbia and some other emerging economies. In Europe, the market is extensively examined by covering U.K., Germany, France, Italy, Spain, Netherlands, Poland, Switzerland and some other promising economies. APAC is further categorised by countries into China, India, Japan, South Korea, Australia & New Zealand, Malaysia, Singapore and many other emerging nations. In the Middle East & African region, Saudi Arabia, UAE, Iran, Iraq, Qatar, South Africa, Algeria, Morocco, Nigeria and so on countries are evaluated to understand the market growth lucidly.
Customization Options:
With the given research report, Envision Inteligence offers customisations as per the client’s specific requirements. The following customisation options offered for the Organs on Chips Market include:
- Scope Revision
- Geographic Analysis
- Company Profiles
- Historical Data & Forecasting
- Key Contact Persons in companies
Global Organs on Chips Market Research Report Includes:
- An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
- To have a complete market analysis through industry value chain analysis, Porter’s Five Force Model, PESTLE, SWOTanalysis, and Y-o-Y analysis.
- Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year
- Identifying DROC in the current market and their impact on altering market dynamics.
- Competitive landscape analysis to identify the merger and acquisition which will have a comparative financial study with significant competitors.
- Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
- Identify the latest developments, market shares and strategies that are employed by the significant Organs on Chips market players, such as
- Nortis Bio
- Ascendance Biotechnology, Inc
- Emulate, Inc.
- Kirkstall
- Hurel Corporation
- Along with these companies, many other companies are considered in the report while analysing the Global Organs on Chips competitive strategies and environment. These companies held substantial share-owning to the nature of the industry whereas, the rest of the market shares are marginal chunks to regional and local level manufacturers. Other players also have considerable presence owing to its robust brand image, geographical reach and stable customer base.
CHAPTER 1. INTRODUCTION
1.1.Market Definition
1.2.Executive Summary
1.3. The Scope of the Study
CHAPTER 2. RESEARCH METHODOLOGY
2.1. Secondary Research
2.2. Primary Research
2.3. Analytic Tools and Model
2.4. Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
CHAPTER 3. MARKET ANALYSIS
3.1. Industry Value Chain Analysis
3.2.Porter’s Five Force Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threats of Substitutes
3.2.4. Threats of New Entrants
3.2.5.Degree of Competition
3.3.PESTLE Analysis
3.3.1. Political
3.3.2. Economical
3.3.3. Social
3.3.4. Technological
3.3.5. Legal
3.3.6. Environmental
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weakness
3.4.3. Opportunities
3.4.4. Threats
3.5. Y-O-Y Analysis
CHAPTER 4. MARKET DYNAMICS
4.1. Market Drivers
4.1.1. Rising number of partnerships and collaborations between companies
4.1.2. Increasing focus on developing alternatives for animal testing models
4.1.3. Rise in research funding and venture capital investments
4.2. Market Restraints & Challenges
4.2.1.The complexity of organs on chips models
4.2.2. Issues related to the incorporation of organs on chips technologies
4.3. Market Opportunities
4.3.1. Growing focus on drug discovery activities
4.3.2. Development of multiple organs on a chip model
CHAPTER 5. GLOBAL ORGAN ON CHIPS MARKET– BY OFFERING
5.1. Introduction
5.2. Products
5.3. Services
CHAPTER 6. GLOBAL ORGAN ON CHIPS MARKET – BY TYPE
6.1. Introduction
6.3. Kidney
6.4. Lung
6.5. Heart
6.6. Other Organs
CHAPTER 7. GLOBAL ORGAN ON CHIPS MARKET – BY APPLICATION
7.1. Introduction
7.2. Drug Discovery
7.3. Physiological Model Development
7.4. Toxicology Research
CHAPTER 8. GLOBAL ORGAN ON CHIPS MARKET – BY END USER
8.1. Introduction
8.2. Cosmetics Industry
8.3. Pharmaceutical & Biotechnology Companies
8.4. Academic & Research Institutes
8.5. Other End Users
CHAPTER 9. GLOBAL ORGAN ON CHIPS MARKET – BY GEOGRAPHY
9.1. Introduction
9.2. North America
9.2.1. The U.S.
9.2.2. Canada
9.2.3. Mexico
9.2.4. Costa Rica
9.3. South America
9.3.1. Brazil
9.3.2. Argentina
9.3.3. Chile
9.3.4. Columbia
9.3.5. Others
9.4. Europe
9.4.1. U.K.
9.4.2. Germany
9.4.3. France
9.4.4. Italy
9.4.5. Spain
9.4.6. Russia
9.4.7. Netherlands
9.4.8. Switzerland
9.4.9. Poland
9.4.10. Others
9.5. APAC
9.5.1. China
9.5.2. Japan
9.5.3. India
9.5.4. South Korea
9.5.5. Australia & New Zealand
9.5.6. Malaysia
9.5.7. Singapore
9.5.8. Others
9.6. Middle East & Africa
9.6.1. UAE
9.6.2. Saudi Arabia
9.6.3. Iran
9.6.4. Iraq
9.6.5. Qatar
9.6.6. South Africa
9.6.7. Algeria
9.6.8. Morocco
9.6.9. Nigeria
9.6.10. Egypt
9.6.11. Others
CHAPTER 10. GLOBAL ORGAN ON CHIPS MARKET – COMPANY PROFILES
10.1. Nortis Bio
10.2. Synvivo
10.3. Tissuse
10.4. Mimetas B.V
10.5. Ascendance Biotechnology, Inc.
10.6. Emulate, Inc.
10.7. Kirkstall
10.8. Hurel Corporation
10.9. InSphero AG
10.10. Axosim Technologies LLC
10.11. CN Bio Innovations
10.12. Tara Biosystems
10.13. Organovo Holdings, Inc.
CHAPTER 11. GLOBAL ORGAN ON CHIPS MARKET – COMPETITIVE
LANDSCAPE
11.1. Market Share Analysis
11.2. Strategies adopted by top companies
11.3. Mergers, Acquisitions, Collaborations & Agreements
CHAPTER 12. MARKET INSIGHTS
12.1. Industry Experts Insights
12.2. Analysts Opinions
12.3. Investment Opportunities
CHAPTER 13. APPENDIX
13.1. List of Tables
13.2. List of Figures
- Competitive Analysis in marketing and strategic management is an assessment of the strengths and weaknesses of current and potential competitors.
- Monitoring the external and internal factors which affect the market dynamics with the aid of PESTLE analysis.
- The Regional and Global Variety is taken care of in the report.
- Year on Year basis generation of revenue is studied.
- Porter's Five Forces analyze the intensity of competition in an industry and its profitability level.
- The overview and the sustainability of the market are analyzed through SWOT.
- DROC (Drivers, Restraints, Opportunities and Challenges) is recognized in the current market scenario and see how its effect on market dynamics.
- The segment-level analysis in terms of type and technology.
- The value chain analysis, value that's created and captured by a company is the profit margin.
- Value Created and Captured – Cost of Creating that Value = Margin
- An executive summary consists of the whole report and the outcome is been given in the report to have brief knowledge about the report.
- Basis on the depth of the study we approach using analytical tools
- Expertise investment opportunities are given after analyzing the market to give the organization and the individual to have perfect knowledge about the market.
Global Report
$2,700.00 – $8,100.00
- EUR: €2,511.39 - €7,534.18
- INR: ₹223,024.12 - ₹669,072.36
- AED: د.إ9,909.00 - د.إ29,727.00
- GBP: £2,180.22 - £6,540.65
Additional information
Report Type | Extensive Report, Miniature report, Snapshot Report |
---|---|
Licence | Single User License, Team License, Corporate License |
An organ-on-a-chip is a microfluidic cell culture device, which is developed by microchip manufacturing methods which contain continuously perfused chambers inhabited by living cells arranged to simulate tissue and organ-level physiology. The organs-on-chips market is expected to reach $85.19 Million by 2024 from $9.6 Million in 2017, at a CAGR of 36.6%. Rising number of partnerships and collaborations between companies and Increasing focus on developing alternatives for animal testing models are the drivers that boost the market growth. Growing focus on drug discovery activities and the development of multiple organs on a chip model are the major opportunities for the market. On the flip side, the complexity of organs on chips models and issues related to the incorporation of organs on chips technologies are the restraints that hamper the market growth.
Research Study Objectives:
- Define, estimate, and forecast the Organs on Chips market statistics by offering, type, application, end user and regions concerning the individual growth drivers, market trends and their contribution toward the Organs on Chips market growth
- Provides comprehensive information regarding the key factors influencing the market growth (Drivers, Restraints &Challenges, and Opportunities)
- Estimate & forecast the market size of all the segments concerning geographies including North America, Europe, Asia Pacific (APAC), South America and the Middle East and Africa (MEA).
- Recent competitive developments including M&A (Mergers and Acquisitions), Partnerships, and Product Innovations are provided in the Organs on Chips Market Analysis report.
- Analysis and conclusions on the future Organs on Chips market outlook.
Top-down and bottom-up approaches are used to validate the Organs on Chips Market Size and are used to estimate the size of other dependent submarkets. Key players in the market are identified through various secondary sources; databases including Bloomberg Businessweek, Hoovers, Factiva, journals and associations and the market revenues are estimated and are thoroughly validated through primary and secondary research. Secondary research involves the study of annual and financial reports of top players in the market, whereas primary research includes extensive interviews with the KoL’s such as CEOs, directors, board members, VP’s, sales managers, engineers, marketing executives, technicians, account managers, investors, strategic decision makers and others. The Organs on Chips Market shares and breakdowns are determined using secondary sources and are verified by the primary sources. All possible parameters/factors that are affecting the Organs on Chips market demand are covered in the research study are verified through primary research, analysed and interpreted to get the final qualitative and quantitative data. This data is collected and added with detailed analysis from Envision Inteligence and presented in this report.
The scope of the Report
The Organs on Chips market segmentation is as follows:
By Offering
- Products
- Services
By Type
- Kidney
- Lung
- Heart
- Other Organs
By Application
- Drug Discovery
- Physiological Model Development
- Toxicology Research
By End User
- Cosmetics Industry
- Pharmaceutical & Biotechnology Companies
- Academic & Research Institutes
- Other End Users
Geographical Analysis:
Organs on Chips Market is segmented by geography into North America, South America, Europe, APAC and Middle East & Africa. U.S., Canada, Mexico and Costa Rica are analysed under North American region which is usually turning as the hotspot in the market. The South American region is further segregated into Brazil, Argentina, Chile, Columbia and some other emerging economies. In Europe, the market is extensively examined by covering U.K., Germany, France, Italy, Spain, Netherlands, Poland, Switzerland and some other promising economies. APAC is further categorised by countries into China, India, Japan, South Korea, Australia & New Zealand, Malaysia, Singapore and many other emerging nations. In the Middle East & African region, Saudi Arabia, UAE, Iran, Iraq, Qatar, South Africa, Algeria, Morocco, Nigeria and so on countries are evaluated to understand the market growth lucidly.
Customization Options:
With the given research report, Envision Inteligence offers customisations as per the client’s specific requirements. The following customisation options offered for the Organs on Chips Market include:
- Scope Revision
- Geographic Analysis
- Company Profiles
- Historical Data & Forecasting
- Key Contact Persons in companies
Global Organs on Chips Market Research Report Includes:
- An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
- To have a complete market analysis through industry value chain analysis, Porter’s Five Force Model, PESTLE, SWOTanalysis, and Y-o-Y analysis.
- Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year
- Identifying DROC in the current market and their impact on altering market dynamics.
- Competitive landscape analysis to identify the merger and acquisition which will have a comparative financial study with significant competitors.
- Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
- Identify the latest developments, market shares and strategies that are employed by the significant Organs on Chips market players, such as
- Nortis Bio
- Ascendance Biotechnology, Inc
- Emulate, Inc.
- Kirkstall
- Hurel Corporation
- Along with these companies, many other companies are considered in the report while analysing the Global Organs on Chips competitive strategies and environment. These companies held substantial share-owning to the nature of the industry whereas, the rest of the market shares are marginal chunks to regional and local level manufacturers. Other players also have considerable presence owing to its robust brand image, geographical reach and stable customer base.
CHAPTER 1. INTRODUCTION
1.1.Market Definition
1.2.Executive Summary
1.3. The Scope of the Study
CHAPTER 2. RESEARCH METHODOLOGY
2.1. Secondary Research
2.2. Primary Research
2.3. Analytic Tools and Model
2.4. Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
CHAPTER 3. MARKET ANALYSIS
3.1. Industry Value Chain Analysis
3.2.Porter’s Five Force Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threats of Substitutes
3.2.4. Threats of New Entrants
3.2.5.Degree of Competition
3.3.PESTLE Analysis
3.3.1. Political
3.3.2. Economical
3.3.3. Social
3.3.4. Technological
3.3.5. Legal
3.3.6. Environmental
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weakness
3.4.3. Opportunities
3.4.4. Threats
3.5. Y-O-Y Analysis
CHAPTER 4. MARKET DYNAMICS
4.1. Market Drivers
4.1.1. Rising number of partnerships and collaborations between companies
4.1.2. Increasing focus on developing alternatives for animal testing models
4.1.3. Rise in research funding and venture capital investments
4.2. Market Restraints & Challenges
4.2.1.The complexity of organs on chips models
4.2.2. Issues related to the incorporation of organs on chips technologies
4.3. Market Opportunities
4.3.1. Growing focus on drug discovery activities
4.3.2. Development of multiple organs on a chip model
CHAPTER 5. GLOBAL ORGAN ON CHIPS MARKET– BY OFFERING
5.1. Introduction
5.2. Products
5.3. Services
CHAPTER 6. GLOBAL ORGAN ON CHIPS MARKET – BY TYPE
6.1. Introduction
6.3. Kidney
6.4. Lung
6.5. Heart
6.6. Other Organs
CHAPTER 7. GLOBAL ORGAN ON CHIPS MARKET – BY APPLICATION
7.1. Introduction
7.2. Drug Discovery
7.3. Physiological Model Development
7.4. Toxicology Research
CHAPTER 8. GLOBAL ORGAN ON CHIPS MARKET – BY END USER
8.1. Introduction
8.2. Cosmetics Industry
8.3. Pharmaceutical & Biotechnology Companies
8.4. Academic & Research Institutes
8.5. Other End Users
CHAPTER 9. GLOBAL ORGAN ON CHIPS MARKET – BY GEOGRAPHY
9.1. Introduction
9.2. North America
9.2.1. The U.S.
9.2.2. Canada
9.2.3. Mexico
9.2.4. Costa Rica
9.3. South America
9.3.1. Brazil
9.3.2. Argentina
9.3.3. Chile
9.3.4. Columbia
9.3.5. Others
9.4. Europe
9.4.1. U.K.
9.4.2. Germany
9.4.3. France
9.4.4. Italy
9.4.5. Spain
9.4.6. Russia
9.4.7. Netherlands
9.4.8. Switzerland
9.4.9. Poland
9.4.10. Others
9.5. APAC
9.5.1. China
9.5.2. Japan
9.5.3. India
9.5.4. South Korea
9.5.5. Australia & New Zealand
9.5.6. Malaysia
9.5.7. Singapore
9.5.8. Others
9.6. Middle East & Africa
9.6.1. UAE
9.6.2. Saudi Arabia
9.6.3. Iran
9.6.4. Iraq
9.6.5. Qatar
9.6.6. South Africa
9.6.7. Algeria
9.6.8. Morocco
9.6.9. Nigeria
9.6.10. Egypt
9.6.11. Others
CHAPTER 10. GLOBAL ORGAN ON CHIPS MARKET – COMPANY PROFILES
10.1. Nortis Bio
10.2. Synvivo
10.3. Tissuse
10.4. Mimetas B.V
10.5. Ascendance Biotechnology, Inc.
10.6. Emulate, Inc.
10.7. Kirkstall
10.8. Hurel Corporation
10.9. InSphero AG
10.10. Axosim Technologies LLC
10.11. CN Bio Innovations
10.12. Tara Biosystems
10.13. Organovo Holdings, Inc.
CHAPTER 11. GLOBAL ORGAN ON CHIPS MARKET – COMPETITIVE
LANDSCAPE
11.1. Market Share Analysis
11.2. Strategies adopted by top companies
11.3. Mergers, Acquisitions, Collaborations & Agreements
CHAPTER 12. MARKET INSIGHTS
12.1. Industry Experts Insights
12.2. Analysts Opinions
12.3. Investment Opportunities
CHAPTER 13. APPENDIX
13.1. List of Tables
13.2. List of Figures
- Competitive Analysis in marketing and strategic management is an assessment of the strengths and weaknesses of current and potential competitors.
- Monitoring the external and internal factors which affect the market dynamics with the aid of PESTLE analysis.
- The Regional and Global Variety is taken care of in the report.
- Year on Year basis generation of revenue is studied.
- Porter's Five Forces analyze the intensity of competition in an industry and its profitability level.
- The overview and the sustainability of the market are analyzed through SWOT.
- DROC (Drivers, Restraints, Opportunities and Challenges) is recognized in the current market scenario and see how its effect on market dynamics.
- The segment-level analysis in terms of type and technology.
- The value chain analysis, value that's created and captured by a company is the profit margin.
- Value Created and Captured – Cost of Creating that Value = Margin
- An executive summary consists of the whole report and the outcome is been given in the report to have brief knowledge about the report.
- Basis on the depth of the study we approach using analytical tools
- Expertise investment opportunities are given after analyzing the market to give the organization and the individual to have perfect knowledge about the market.
Our Clientele
Exclusive Benefits
Credibility and Transparency
We actively recruit consumers, business professionals, and hard-to-reach individuals as members of our research panels, and we build trusted, ongoing relationships with them. Thus we provide the complete list of primary and secondary data sources in the report to maintain the transparency and to assure the credibility.
Exhaustive Coverage
Detailed and extensive coverage in the geography.Survey consultation for brand tracking, concept testing, consumer behaviour, and more, we have you covered with market research services that scale to meet your needs.
Competitive Edge
Our reports cover most recent updates in the market till the date of the purchase. We identify, gather and timely deliver analysis on impact of unprecedented decisions of CXOs in COVID-19 catastrophe on many businesses, their clients and their clients' clients without additional cost.
Golden Opportunities
A comprehensive strategic sieve analysis of the market by our analysts and consultants, aided by AI tools helps us find the non-obvious, golden and emerging opportunities for you to evaluate.
Top-notch Reports Guaranteed
70% of our research is exclusive; no other research firm has the depth and breadth of our research.
Post Purchase Support
Post-purchase support is provided for all our reports, for three months from the date of purchase, where related queries will be answered within 24 business hours over telephone or email.